Solid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Rating of Buy from Analysts

Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have earned a consensus recommendation of “Buy” from the six ratings firms that are currently covering the company, MarketBeat reports. Six research analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have issued a report on […]

Related Keywords

United States ,William Blair ,Piper Sandler ,Barclays ,Citigroup ,Vanguard Group Inc ,Janus Henderson Group ,Nasdaq ,Solid Biosciences Inc ,Bain Capital Life Sciences Investors ,Artal Group ,Solid Biosciences ,Get Free Report ,Henderson Group ,Capital Life Sciences Investors ,Vanguard Group ,Get Free ,Biosciences Inc ,Solid Biosciences Daily ,